Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science,Pharmacy
Reference6 articles.
1. Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use;Brown;J Clin Med,2019
2. Immune Responses Regulated by Cannabidiol. Cannabis and Cannabinoid Research;Nichols,2019
3. Potential adverse drug events with Tetrahydrocannabinol (THC) due to drug–drug interactions;Brown;J Clin Med,2020
4. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?;Fang;Lancet Respir Med,2020
5. Antihypertensive drugs and risk of COVID-19?;Brown;Lancet Respir Med,2020
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review;Frontiers in Immunology;2023-03-22
2. Detecting Tweets Containing Cannabidiol-Related COVID-19 Misinformation Using Transformer Language Models and Warning Letters From Food and Drug Administration: Content Analysis and Identification;JMIR Infodemiology;2023-01-23
3. Phytomolecules and Novel Drug Delivery Approach for COVID-19;Viral Drug Delivery Systems;2023
4. Cannabidiol As a Treatment for COVID-19 Symptoms? A Critical Review;Cannabis and Cannabinoid Research;2022-07-26
5. Israeli news media coverage of COVID-19 and use of cannabis and tobacco: A case study of inconsistent risk communication;International Journal of Drug Policy;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3